Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells

Stem Cell Research

Volumn 9, Issue 3, 2012, Pages 249-260

  Jaiswal, Kshama R ^a,b   Xin, Hong Wu ^a   Anderson, Andrew ^a   Wiegand, Gordon ^a   Kim, Bo ^a   Miller, Tyler ^a   Hari, Danielle ^a   Ray, Satyajit ^a   Koizumi, Tomotake ^a   Rudloff, Udo ^a   Thorgeirsson, Snorri S ^a   Avital, Itzhak ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD20 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; EPITHELIAL CELL ADHESION MOLECULE; GEMCITABINE; HERMES ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; CELL HETEROGENEITY; CELL POPULATION; CELL SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; PANCREAS CANCER; PANCREATIC CANCER STEM CELL; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD; CELL LINE; HUMANS; MALE; MICE; MIDDLE AGED; NEOPLASTIC STEM CELLS; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED;

MUS MUSCULUS;

EID: 84865814492     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2012.08.001     Document Type: Article

References (29)

1. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3:730-737.
2. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H., Jones D.L., Visvader J., Weissman I.L., Wahl G.M. Cancer stem cells - perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006, 66:9339-9344.
3. Dai L., Li C., Shedden K.A., Lee C.J., Li C., Quoc H., Simeone D.M., Lubman D.M. Quantitative proteomic profiling studies of pancreatic cancer stem cells. J. Proteome. Res. 2010, 9(7):3394-3402. (Jul 2).
4. Das B., Tsuchida R., Malkin D., Koren G., Baruchel S., Yeger H. Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells 2008, 26:1818-1830.
5. Goodell M.A., Brose K., Paradis G., Conner A.S., Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 1996, 183:1797-1806.
6. Han J.S., Crowe D.L. Tumor initiating cancer stem cells from human breast cancer cell lines. Int. J. Oncol. 2009, 34:1449-1453.
7. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., Bruns C.J., Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313-323.
8. Hermann P.C., Mueller M.-T., Heeschen C. Pancreatic cancer stem cells - insights and perspectives. Expert. Opin. Biol. Ther. 2009, 9:1271-1278.
9. SEER Cancer Statistics Review, 1975-2006 2009, National Cancer Institute, Bethesda, MD, posted to the SEER web site, 2009. M.J. Horner, R. L., M. Krapcho, N. Neyman, R. Aminou, N. Howlader, S.F. Altekruse, E.J. Feuer, L. Huang, A. Mariotto, B.A. Miller, D.R. Lewis, M.P. Eisner, D.G. Stinchcomb, B.K. Edwards (Eds.).
10. Jimeno A., Feldmann G., Suárez-Gauthier A., Rasheed Z., Solomon A., Zou G.-M., Rubio-Viqueira B., García-García E., López-Ríos F., Matsui W., et al. A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Mol. Cancer Ther. 2009, 8:310-314.
11. Kallifatidis G., Rausch V., Baumann B., Apel A., Beckermann B.M., Groth A., Mattern J., Li Z., Kolb A., Moldenhauer G., et al. Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut 2009, 58:949-963.
12. Kleinman H.K., Martin G.R. Matrigel: Basement membrane matrix with biological activity. Semin. Cancer Biol. 2005, 15:378-386.
13. Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., Wicha M., Clarke M.F., Simeone D.M. Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67:1030-1037.
14. Lonardo E., Hermann P.C., Heeschen C. Pancreatic cancer stem cells - update and future perspectives. Mol. Oncol. 2010, 4:431-442.
15. Mueller M.-T., Hermann P.C., Witthauer J., Rubio-Viqueira B., Leicht S.F., Huber S., Ellwart J.W., Mustafa M., Bartenstein P., D'Haese J.G., et al. Combined Targeted Treatment to Eliminate Tumorigenic Cancer Stem Cells in Human Pancreatic Cancer. Gastroenterology 2009, 137:1102-1113.
16. Nagaoka M., Si-Tayeb K., Akaike T., Duncan S. Culture of human pluripotent stem cells using completely defined conditions on a recombinant E-cadherin substratum. BMC Dev. Biol. 2010, 10:60.
17. Ning Z.F., Huang Y.J., Lin T.X., Zhou Y.X., Jiang C., Xu K.W., Huang H., Yin X.B., Huang J. Subpopulations of Stem-like Cells in Side Population Cells from the Human Bladder Transitional Cell Cancer Cell Line T24. J. Int. Med. Res. 2009, 37:621-630.
18. Noble S., Goa K.L. Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer. Drugs 1997, 54:447-472.
19. Quintana E., Shackleton M., Sabel M.S., Fullen D.R., Johnson T.M., Morrison S.J. Efficient tumour formation by single human melanoma cells. Nature 2008, 456:593-598.
20. Rausch V., Liu L., Kallifatidis G., Baumann B., Mattern J., Gladkich J., Wirth T., Schemmer P., Buchler M.W., Zoller M., et al. Synergistic Activity of Sorafenib and Sulforaphane Abolishes Pancreatic Cancer Stem Cell Characteristics. Cancer Res. 2010, 70(12):5004-5013. (Jun 15, Epub 2010 Jun 8).
21. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
22. Rosen J.M., Jordan C.T. The increasing complexity of the cancer stem cell paradigm. Science 2009, 324:1670-1673.
23. Sergeant G., Vankelecom H., Gremeaux L., Topal B. Role of cancer stem cells in pancreatic ductal adenocarcinoma. Nat. Rev. Clin. Oncol. 2009, 6:580-586.
24. Tavaluc R.T., Hart L.S., Dicker D.T., El-Deiry W.S. Effects of low confluency, serum starvation and hypoxia on the side population of cancer cell lines. Cell Cycle 2007, 6:2554-2562.
25. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 2008, 8:755-768.
26. Vlashi E., McBride W.H., Pajonk F. Radiation responses of cancer stem cells. J. Cell. Biochem. 2009, 108:339-342.
27. Wu C., Alman B.A. Side population cells in human cancers. Cancer Lett. 2008, 268:1-9.
28. Yao J., Cai H.H., Wei J.S., An Y., Ji Z.L., Lu Z.P., Wu J.L., Chen P., Jiang K.R., Dai C.C., et al. Side population in the pancreatic cancer cell lines SW1990 and CFPAC-1 is enriched with cancer stem-like cells. Oncol. Rep. 2010, 23:1375-1382.
29. Zhou J., Wang C.Y., Liu T., Wu B., Zhou F., Xiong J.X., Wu H.S., Tao J., Zhao G., Yang M., Gou S.M. Persistence of side population cells with high drug efflux capacity in pancreatic cancer. World J. Gastroenterol. 2008, 14:925-930.